Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Timothy Stover | VP, Corporate Controller | $138K | Aug 30, 2023 | ||
Jerome B. Zeldis | Executive VP of Research & Dev | Apr 5, 2022 | |||
Sol J. Barer | Director | Jul 5, 2023 | |||
Zhengbin Yao | Director | Jul 5, 2023 | |||
Timothy Bertram | Director | Jul 5, 2023 | |||
John Trainer | Chief Financial Officer | Apr 4, 2023 | |||
Alan S. Roemer | Director | Nov 21, 2023 | |||
Albert N. Marchio II | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney | Apr 5, 2024 | |||
Kristi Jones | President and CEO, Director | Jun 11, 2024 | |||
Mathias Oelke | Chief Science Officer | Apr 4, 2023 | |||
Robert Douglas Knight | Chief Medical Officer | Apr 5, 2022 | |||
Leena Gandhi | Director | Jul 5, 2023 | |||
Paul D'Angio | Director | Jul 5, 2023 | |||
Grant Verstandig | Director | Jul 5, 2023 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|